TD Cowen Issues Pessimistic Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target cut by stock analysts at TD Cowen from $340.00 to $323.00 in a research note issued to investors on Thursday,MarketScreener reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. TD Cowen’s price objective points to a potential upside of 13.32% from the stock’s current price.

Other analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft raised their target price on CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Barclays lowered their target price on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research note on Thursday. Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. Erste Group Bank upgraded CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Finally, Raymond James Financial raised their target price on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, CME Group presently has a consensus rating of “Moderate Buy” and an average price target of $306.71.

CME Group Stock Down 0.2%

Shares of CME Group stock opened at $285.02 on Thursday. The business has a 50-day moving average of $304.51 and a 200-day moving average of $286.07. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.03. The company has a market capitalization of $102.22 billion, a PE ratio of 24.32, a P/E/G ratio of 3.02 and a beta of 0.26. CME Group has a 1-year low of $257.17 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the firm earned $2.80 earnings per share. As a group, equities analysts forecast that CME Group will post 12.26 EPS for the current fiscal year.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction dated Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the transaction, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the transaction, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. This trade represents a 1.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 8,539 shares of company stock valued at $2,713,821 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On CME Group

A number of hedge funds have recently bought and sold shares of CME. Norges Bank acquired a new position in CME Group in the fourth quarter worth about $1,523,241,000. Sanders Capital LLC bought a new position in CME Group in the third quarter worth about $1,006,932,000. Strive Asset Management LLC bought a new position in CME Group in the third quarter worth about $636,487,000. Victory Capital Management Inc. lifted its holdings in CME Group by 746.4% in the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after acquiring an additional 1,807,491 shares during the last quarter. Finally, Life Cycle Investment Partners Ltd bought a new position in CME Group in the fourth quarter worth about $217,656,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes: CME reported record Q1 revenue and a surge in trading volumes, driven by higher hedging and risk-management activity — a core driver of futures and options trading revenue. Article Title
• Positive Sentiment: Earnings-call commentary backs the volume story: Management emphasized broad-based demand and rising market risk that is increasing hedging flows — a positive outlook for transaction-driven revenue. Article Title Article Title
• Positive Sentiment: Full earnings transcript available for deeper color: Investors can review management’s detail on volume drivers and segment performance. Article Title
• Neutral Sentiment: Multiple analysts trimmed price targets but kept constructive ratings: Deutsche Bank cut its PT to $322 (keeps buy) and TD Cowen cut to $323 (keeps buy); Morgan Stanley trimmed to $353 but retained overweight — these lower targets reflect model updates despite continued positive ratings. Article Title Article Title Article Title
• Neutral Sentiment: No meaningful short-interest signal: the short-interest data published for April is effectively zero/unchanged and does not explain the move. (No linked article.)
• Negative Sentiment: Goldman maintains a sell rating and lowered its PT to $267 — the most bearish big-bank view in the group and a direct negative for sentiment. Article Title
• Negative Sentiment: Mixed market reaction and some headline takes that Q1 sales missed analyst expectations or that the stock looks expensive post-earnings — these narratives can pressure short-term price action despite strong volume trends. Article Title Article Title

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.